A fresh look at what a vaginal moisturizer should be, based on today’s science.

Schmear of Via vaginal moisturizer on top of a petri dish

Via contains a proprietary blend of clinically studied active ingredients in state-of-the-art carriers:

Hyaluronic acid – A humectant with potent water-binding capacity.1,2,3

Vitamin E & CoQ10 – A combination of dl-α-Tocopheryl Acetate (Vitamins E) & Ubiquinone (coenzyme Q-10). Aids in restoration of the lipid barrier and promotes cell membrane functionality.4

Vitamin C – Tetrahexyldecyl Ascorbate is a free radical scavenger retained in the epidermis and, to some extent, in the dermis with longer lasting anti-oxidant activity than Ascorbic Acid.5

Peptides (amino acids) – Support collagen and elastin, aiding tissue hydration and resilience.6,7

Jojoba oil – Accelerates wound healing, promotes hydration, and smoother and softer skin.8

How to use Via:

  1. Dispense 2 pumps (a dime-sized amount) onto a clean, dry finger or onto the tip of the applicator.
  2. Apply the lotion up to 1 inch inside the vaginal canal.
  3. Gently apply the lotion to the external opening of your vagina (vulva).
  4. Wash your hands and the applicator with soap and warm water after each use.
  5. Apply at least 3 times per week. For best results, use daily.
anatomy diagram
Via Vaginal Moisturizer Sample Size

Just one year into menopause, two-thirds of women say they experience vaginal dryness.9 And eight years after menopause, that number rises to 84%.10

And yet, only 25% seek treatment.11 That means too many women just “grin and bear it.”

Get your patients started the day they leave your office with free samples.

Clinical citations:

    1. 1. Junya Chen et al., “Evaluation of the Efficacy and Safety of Hyaluronic Acid Vaginal Gel to Ease Vaginal Dryness: A Multicenter, Randomized, Controlled, Open‐Label, Parallel‐Group, Clinical Trial,” The Journal of Sexual Medicine, (2013) Vol. 10, Issue 6, p. 1575-84.
    2. 2. Carlos Campagnaro M. dos Santos et al., “Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review,” The Journal of Sexual Medicine (2021) Vol. 18, Issue 1, p. 156-66.
    3. 3. Buzzaccarini et al., (2021) “Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review,” Climacteric, Vol. 24:6, p. 560-71.
    4. 4. Marcheggiani F et al., “Anti-ageing effects of ubiquinone and ubiquinol in a senescence model of human dermal fibroblasts.” Free Radic Biol Med. (Mar. 2021), Vol. 165, p. 282-8.
    5. 5. Stamford NP. Stability, transdermal penetration, and cutaneous effects of ascorbic acid and its derivatives. J Cosmet Dermatol. 2012 Dec;11(4):310-7.
      doi: 10.1111/jocd.12006. PMID: 23174055.
    6. 6. Vorster, Aug. 2013 ., et al. “The magical ingredients: anti-ageing. South African Pharmaceutical and Cosmetic Review,” 40(8):22-25.
    7. 7. Howard I. Maibach et al.“Role of topical peptides in preventing or treating aged skin”. International Journal of Cosmentic Science (Aug. 2009), Vol. 31, Is. 5, p. 327-45.
    8. 8. Ranzato E, Martinotti S, Burlando B. “Wound healing properties of jojoba liquid wax: an in vitro study.” Ethnopharmacol. (Mar 2011) 24;134(2), p. 443-9.
    9. 9. Cagnacci A. et al. “Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study,” Menopause (Oct 2016), 23(10), p. 1139-45.
    10. 10. Ayane Cristine Alves Sarmento et al. “Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation, and Diagnostic.” Frontiers in Reproductive Health, Nov 2021), Vol. 3.
    11. 11. Sturdee, D. W., Panay, N., & International Menopause Society Writing Group (2010). Recommendations for the management of postmenopausal vaginal atrophy. Climacteric: The Journal of the International Menopause Society, 13(6), 509–522.